News
The head of the EU's pharmaceutical lobby has called for the creation of a life sciences-focused stock market in Europe, ...
Frost & Sullivan commends Novotech for setting a high standard in competitive strategy, execution, and market responsiveness.
US-Japan venture capital firm AN Venture Partners has wrapped up its first fund at $200 million, marking one of the largest ...
AN Venture Partners has closed its first fund, a $200 million vault for biotechs worldwide, with particular emphasis on ...
Responding to the European Commission’s call for evidence, Biovia says regulatory delays, fragmented markets, and lack of ...
Biotech Showcase™ 2025 Opens the Year with More than 3,000 Attendees, 340+ Presenting Companies, 1,020+ Investors and 85+ Members of the Media ...
The NATO Innovation Fund has made its first investment in a biotechnology company, it said on Monday, seeking to enhance ...
How to Encourage Biotech Innovation. Letter to the Editor. July 31, ...
Financial incentives from state governments are part of a growing trend of policies designed to spur innovation clusters in specific regions. Biotechnology industry clusters in particular have ...
The recent National Institutes of Health funding cuts and proposed caps on indirect costs are raising concerns not only about the future of scientific innovation but also about potential economic ...
Hosted on MSN5mon
I Was Convinced Biotech Stocks Were Too Risky—This Innovation’s Changing the Game - MSNThe biotech scene can be seen as fairly risky for new investors who want to put money to work. After all, it's really tough to gauge which innovative biotech firms will have something genuinely ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results